These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Spread of Creutzfeldt-Jakob disease virus along visual pathways after intraocular inoculation. Liberski PP; Yanagihara R; Gibbs CJ; Gajdusek DC Arch Virol; 1990; 111(1-2):141-7. PubMed ID: 2183743 [TBL] [Abstract][Full Text] [Related]
7. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Bruce ME; McConnell I; Will RG; Ironside JW Lancet; 2001 Jul; 358(9277):208-9. PubMed ID: 11476840 [TBL] [Abstract][Full Text] [Related]
8. Kinetics of infectivity are dissociated from PrP accumulation in salivary glands of Creutzfeldt-Jakob disease agent-inoculated mice. Sakaguchi S; Katamine S; Yamanouchi K; Kishikawa M; Moriuchi R; Yasukawa N; Doi T; Miyamoto T J Gen Virol; 1993 Oct; 74 ( Pt 10)():2117-23. PubMed ID: 8409936 [TBL] [Abstract][Full Text] [Related]
9. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Telling GC; Scott M; Hsiao KK; Foster D; Yang SL; Torchia M; Sidle KC; Collinge J; DeArmond SJ; Prusiner SB Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9936-40. PubMed ID: 7937921 [TBL] [Abstract][Full Text] [Related]
10. [Prions, Jakob-Creutzfeldt disease and human growth hormone]. González PM Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(5):207-9. PubMed ID: 3296112 [No Abstract] [Full Text] [Related]
11. Successful transmission of Creutzfeldt-Jakob disease from human to mouse verified by prion protein accumulation in mouse brains. Muramoto T; Kitamoto T; Tateishi J; Goto I Brain Res; 1992 Dec; 599(2):309-16. PubMed ID: 1291035 [TBL] [Abstract][Full Text] [Related]
12. A traceback phenomenon can reveal the origin of prion infection. Kobayashi A; Asano M; Mohri S; Kitamoto T Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941 [TBL] [Abstract][Full Text] [Related]
13. [Review of Creutzfeldt-Jakob disease and other prion diseases]. Zivkovic S; Boada M; López O Rev Neurol; 2000 Dec 16-31; 31(12):1171-9. PubMed ID: 11205554 [TBL] [Abstract][Full Text] [Related]
14. Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology? Kobayashi A; Parchi P; Yamada M; Brown P; Saverioni D; Matsuura Y; Takeuchi A; Mohri S; Kitamoto T J Virol; 2015 Apr; 89(7):3939-46. PubMed ID: 25609817 [TBL] [Abstract][Full Text] [Related]
15. Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents. Tateishi J; Kitamoto T; Hoque MZ; Furukawa H Neurology; 1996 Feb; 46(2):532-7. PubMed ID: 8614527 [TBL] [Abstract][Full Text] [Related]
16. Experimental transmission of Creutzfeldt-Jakob disease. Tateishi J; Koga M; Mori R Acta Pathol Jpn; 1981 Nov; 31(6):943-51. PubMed ID: 7032196 [TBL] [Abstract][Full Text] [Related]
17. The infectivity is dissociated from PrP accumulation in salivary gland of Creutzfeldt-Jakob disease agent-inoculated mice. Miyamoto T; Sakaguchi S; Katamine S; Moriuchi R Ann N Y Acad Sci; 1994 Jun; 724():310-3. PubMed ID: 7913302 [No Abstract] [Full Text] [Related]
18. Risk of variant Creutzfeldt-Jakob disease and tonsillectomy. Tysnes OB Eur Arch Otorhinolaryngol; 2003 Sep; 260(8):410-1. PubMed ID: 12720005 [No Abstract] [Full Text] [Related]
19. Modulation of Creutzfeldt-Jakob disease prion propagation by the A224V mutation. Watts JC; Giles K; Serban A; Patel S; Oehler A; Bhardwaj S; Guan S; Greicius MD; Miller BL; DeArmond SJ; Geschwind MD; Prusiner SB Ann Neurol; 2015 Oct; 78(4):540-53. PubMed ID: 26094969 [TBL] [Abstract][Full Text] [Related]